Vision Ventures

Vision Ventures is a Saudi-based fund created by entrepreneurs for entrepreneurs, with an early-stage thesis on startups aiming to leapfrog legacy models. Check sizes of $250k to $1M place the firm in the seed range, suitable for participating in or anchoring small priced rounds. Healthcare exposure includes health IT, healthcare software, and wellness/consumer health, with explicit AI thematic interest. The input record cites Madeed and Seerlinq as portfolio examples in the preventative health and Saudi tech space.

The firm’s natural fit is with founders building technology-led health and wellness platforms with Saudi or broader GCC commercial relevance. The entrepreneur-led ethos translates into an operationally engaged investor approach, with hands-on involvement in product, GTM, and hiring. The right founder profile is a technical or operationally savvy team building B2B or B2B2C software with a Vision 2030-aligned thesis, including preventative care, employer health, AI-enabled clinical workflow, and consumer wellness. Founders building deep biotech, clinical therapeutics, or pure US-market plays are not the natural target.

Geographically, Vision Ventures’ advantage is the Saudi market and its broader GCC connectivity. The firm is based in Dammam, which provides differentiated access to Eastern Province corporate stakeholders and operations, complementary to Riyadh-based funds. For founders with Saudi or GCC ambitions, the firm can plausibly help with regulatory navigation, corporate partnerships, and follow-on capital from PIF-affiliated and broader regional funds.

The right entry path is a warm intro from a portfolio founder or from a regional accelerator like Misk or Flat6Labs. The firm reads partner-led decks and responds to clear theses with Saudi market relevance. The pitch should lead with the leapfrog narrative (how does your product define a new category rather than incrementally improving an existing one?), the Saudi commercial wedge, and a credible follow-on plan. AI narrative should connect to specific clinical or operational outcomes.

Caveats. Saudi market dynamics evolve quickly with Vision 2030 sector priorities; what is favored today may shift, and founders should be alert to those shifts. The firm’s healthcare-specific portfolio depth is not as visible publicly as that of dedicated regional health funds; reference calls with portfolio founders, including Madeed and Seerlinq, are advisable. The check range is narrow; for founders raising larger seeds, Vision Ventures should be a participant alongside a real lead. For Saudi-anchored founders building leapfrog health and wellness platforms with Vision 2030 alignment, Vision Ventures is a credible early partner.